Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Exciting News did nothing for share price

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Aug 13, 2024 7:42pm

181 Views

Post# 36177627

RE:Exciting News did nothing for share price

This will most likely be bought out before FDA approval IMO, and north of $10 a share , thats our ticket, we need BTD and AA first, but Big Pharma will not let this ride beyond that because of all the indications we have.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant